See also this year's filing and all EDGAR filings for this company.
PDF Report 0001399529_2019_Dicerna_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001399529')"} |
Graph
Absolute values for 0001399529, Dicerna Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 405,514,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,718,000 |
| 3 | remainder_Assets | 809,000 |
| 4 | LiabilitiesCurrent | 94,055,000 |
| 5 | LiabilitiesNoncurrent | 114,293,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,685,000 |
| 9 | ResearchAndDevelopmentExpense | 45,711,000 |
| 10 | remainder_Expenses | 29,132,000 |
| 11 | remainder_Revenues | 6,176,000 |
| 12 | remainder_NetIncome | 1,499,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 409,041,000 |
| 1 | Liabilities | 208,348,000 |
| 2 | Expenses | 96,528,000 |
| 3 | Revenues | 6,176,000 |
| 4 | StockholdersEquity | 200,693,000 |
| 5 | NetIncome | -88,853,000 |
| 6 | ComprehensiveNetIncome | -88,853,000 |
| 7 | BaseVar | 360,796,000 |
| 8 | EconomicCapitalRatio | 0.830 |